| Literature DB >> 35378940 |
Hualiu Hua1, Baixiang Zhang2, Xiuling Wang2, Yixian He2, Mengting Lai2, Ninghua Chen2, Juan Liu2.
Abstract
Stroke is a group of diseases caused by the sudden rupture or blockage of blood vessels in the brain that prevent blood from flowing into the brain, resulting in brain tissue damage and dysfunction. Stroke has the characteristics of high morbidity, high disability, and high mortality. To investigate the effect of multidirectional transcranial direct current stimulation (tDCS) of the prefrontal lobe in stroke memory disorder. We evaluated 60 patients with poststroke memory impairment who underwent magnetic resonance diffusion tensor imaging (DTI) during their admission to our hospital between January 2018 and December 2020. The patients were divided into the prefrontal group (n = 15), dorsolateral group (n = 15), prefrontal + dorsolateral group (n = 15), and pseudostimulation group (n = 15). Assessments using the Rivermead Behavioral Memory Test (RBMT), Montreal Cognitive Assessment Scale (MoCA), Lovingston Occupational Therapy Cognitive Scale (LOTCA), and frontal lobe fractional anisotropy (FA) were performed before and after treatment. The RBMT, MoCA, and LOTCA scores in the prefrontal + dorsolateral group were significantly higher than those in the dorsolateral, prefrontal, and sham groups (all P < 0.05). The posttreatment FA value of the frontal lobe was significantly higher in the prefrontal + dorsolateral group than in the dorsolateral, prefrontal, and sham stimulation groups (all P < 0.05). The FA value of the frontal lobe was significantly lower in patients with severe memory impairment than in patients with mild-moderate memory impairment (P < 0.05). The area under the receiver operating characteristic curve was 0.801 (95% CI: 0.678-0.925, P < 0.05), and the optimal cut-off value was 0.34, with a sensitivity and specificity of 81.60% and 72.70%, respectively. Prefrontal lobe + dorsolateral tDCS is beneficial in the treatment of post-stroke memory impairment. The DTI FA value can be useful in determining the degree of memory impairment.Entities:
Mesh:
Year: 2022 PMID: 35378940 PMCID: PMC8976647 DOI: 10.1155/2022/2545762
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 2.682
Clinicodemographic patient characteristics by group.
| Groups | Cases | Sex | Age (years) | Course of disease (months) | Brain injury side | Types of stroke | |||
|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Lift | Right | Cerebral infarction | Cerebral hemorrhage | ||||
| Prefrontal lobe + dorsolateral group | 15 | 9 (60.00) | 6 (40.00) | 66.65 ± 4.15 | 4.03 ± 0.98 | 4 (26.67) | 11 (73.33) | 9 (60.00) | 6 (40.00) |
| Dorsolateral group | 15 | 10 (66.67) | 5 (33.33) | 65.26 ± 3.89 | 3.92 ± 1.00 | 5 (33.33) | 10 (66.67) | 11 (73.33) | 4 (26.67) |
| Prefrontal group | 15 | 8 (53.33) | 7 (46.67) | 66.10 ± 4.20 | 3.98 ± 0.89 | 6 (40.00) | 9 (60.00) | 10 (66.67) | 5 (33.33) |
| Sham stimulation group | 15 | 10 (66.67) | 5 (33.33) | 66.03 ± 5.03 | 4.00 ± 1.02 | 5 (33.33) | 10 (66.67) | 10 (66.67) | 5 (33.33) |
|
| 0.776 | 0.26 | 0.034 | 0.600 | 0.600 | ||||
|
| 0.855 | 0.854 | 0.991 | 0.896 | 0.896 | ||||
Pre and posttreatment RBMT, MoCA, and LOTCA scores by group.
| Groups | Cases | RBMT | MoCA | LOTCA | |||
|---|---|---|---|---|---|---|---|
| Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | ||
| Prefrontal lobe + dorsolateral group | 15 | 13.52 ± 1.89 | 18.03 ± 2.01abcd | 23.15 ± 1.65 | 27.51 ± 1.57abcd | 89.65 ± 6.03 | 103.36 ± 7.66abcd |
| Dorsolateral group | 15 | 13.41 ± 2.03 | 16.60 ± 1.87ad | 23.03 ± 1.73 | 25.26 ± 1.53ad | 90.15 ± 5.97 | 95.59 ± 3.46ad |
| Prefrontal group | 15 | 14.22 ± 1.94 | 16.15 ± 1.90ad | 23.32 ± 1.82 | 25.10 ± 1.97ad | 88.97 ± 7.10 | 96.03 ± 4.01ad |
| Sham stimulation group | 15 | 13.98 ± 1.95 | 14.02 ± 1.91 | 23.19 ± 1.90 | 23.26 ± 1.88 | 89.24 ± 6.69 | 90.01 ± 5.57 |
|
| 0.574 | 11.171 | 0.068 | 14.87 | 0.095 | 15.282 | |
|
| 0.634 | 0.000 | 0.977 | 0.000 | 0.963 | 0.000 | |
Note: a, compared with the sham stimulation group, P < 0.05; b, compared with the prefrontal lobe group, P < 0.05; c, compared with the dorsolateral group (P < 0.05); d, compared with before treatment, P < 0.05.
Pre and posttreatment FA values in the frontal lobe by group.
| Groups | Cases | FA | |
|---|---|---|---|
| Before treatment | After treatment | ||
| Prefrontal lobe + dorsolateral group | 15 | 0.39 ± 0.10 | 0.65 ± 0.12abcd |
| Dorsolateral group | 15 | 0.40 ± 0.08 | 0.51 ± 0.10ad |
| Prefrontal group | 15 | 0.41 ± 0.07 | 0.50 ± 0.09ad |
| Sham stimulation group | 15 | 0.38 ± 0.06 | 0.39 ± 0.07 |
|
| 0.402 | 18.222 | |
|
| 0.752 | 0.000 | |
Note: a, compared with sham stimulation group, P < 0.05; b, compared with prefrontal lobe group, P < 0.05; c, compared with dorsolateral group (P < 0.05); d, compared with before treatment, P < 0.05.
Comparison of FA values in frontal lobe of patients with different degrees of stroke memory impairment.
| Groups | Cases | FA |
|
|
|---|---|---|---|---|
| Mild to moderate | 49 | 0.45 ± 0.09 | 3.105 | 0.003 |
| Severe | 11 | 0.36 ± 0.07 |
Figure 1ROC curve.